FI920263A0 - NYA POLYPEPTIDER, PLASMIDER SOM KODAR FOER DESSA SAMT FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING. - Google Patents

NYA POLYPEPTIDER, PLASMIDER SOM KODAR FOER DESSA SAMT FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.

Info

Publication number
FI920263A0
FI920263A0 FI920263A FI920263A FI920263A0 FI 920263 A0 FI920263 A0 FI 920263A0 FI 920263 A FI920263 A FI 920263A FI 920263 A FI920263 A FI 920263A FI 920263 A0 FI920263 A0 FI 920263A0
Authority
FI
Finland
Prior art keywords
foer
deras
plasmider
polypeptider
nya
Prior art date
Application number
FI920263A
Other languages
Finnish (fi)
Other versions
FI920263A (en
Inventor
Gerd J Steffens
Wolfgang A Guenzler
Leopold Flohe
Regina E Brigelius-Flohe
Bernhard Wolf
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of FI920263A0 publication Critical patent/FI920263A0/en
Publication of FI920263A publication Critical patent/FI920263A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6462Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153Streptokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Polypeptides of the general formula Ser-X1-X2-rscuPA<143-411> (1) in which X1 and X2 are defined amino acids or lower peptide bridges, X2 can also be a single bond, and rscuPA<143-411> is the unglycosylated sequence region of amino acids 143 (Glu) to 411 (LeuOH) from scu-PA 54 k, which can be used as plasminogen activators are described. To obtain these compounds, plasmids which are described in detail as such or in terms of their isolation were produced and expression thereof in suitable bacterial hosts provides, in each case in high yields, an expression product which does not act as plasminogen activator but whose protein-chemical conversion then leads to the single-chain compounds of the formula I which are valuable as plasminogen activators. <IMAGE>
FI920263A 1991-01-22 1992-01-21 NYA POLYPEPTIDER, PLASMIDER SOM KODAR FOER DESSA SAMT FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING. FI920263A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4101736A DE4101736A1 (en) 1991-01-22 1991-01-22 NEW PLASMINOGENACTIVATORS USEFUL POLYPEPTIDES, DAFUER CODING PLASMIDS AND METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Publications (2)

Publication Number Publication Date
FI920263A0 true FI920263A0 (en) 1992-01-21
FI920263A FI920263A (en) 1992-07-23

Family

ID=6423453

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920263A FI920263A (en) 1991-01-22 1992-01-21 NYA POLYPEPTIDER, PLASMIDER SOM KODAR FOER DESSA SAMT FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.

Country Status (15)

Country Link
EP (1) EP0496327B1 (en)
JP (1) JPH06169770A (en)
AT (1) ATE204326T1 (en)
DE (2) DE4101736A1 (en)
DK (1) DK0496327T3 (en)
ES (1) ES2164048T3 (en)
FI (1) FI920263A (en)
HK (1) HK1010108A1 (en)
HU (1) HU212510B (en)
IE (1) IE914040A1 (en)
IL (1) IL100163A0 (en)
LT (1) LT3948B (en)
LV (1) LV10974A (en)
PT (1) PT496327E (en)
RU (1) RU2108387C1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017877A (en) * 1990-04-06 2000-01-25 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
KR100225511B1 (en) * 1994-12-30 1999-10-15 성재갑 Process for the mass production of bovine growth hormone
CA2322622A1 (en) * 1998-03-06 1999-09-10 Abbott Laboratories Highly crystalline urokinase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88932C (en) * 1982-04-15 1993-07-26 Genentech Inc Preparation of functional human urokinase protein
NL8601240A (en) 1986-05-15 1987-12-01 Leuven Res & Dev Vzw PLASMINOGEN ACTIVATOR AND THROMBOLYTIC MEDICINAL PRODUCT.
JPH02438A (en) * 1987-10-09 1990-01-05 Collaborative Res Inc Modified low molecular weight plasminogen activated factor and production thereof
DE3735917A1 (en) * 1987-10-23 1989-05-03 Basf Ag NEW POLYPEPTIDES, THEIR PRODUCTION AND USE
DE3810474A1 (en) * 1988-03-26 1989-10-05 Boehringer Ingelheim Int Expression vectors
GB8809093D0 (en) * 1988-04-18 1988-05-18 Erba Carlo Spa Low molecular weight derivatives of prourokinase
AU5515790A (en) * 1989-05-18 1990-11-22 Green Cross Corporation, The Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator

Also Published As

Publication number Publication date
EP0496327A1 (en) 1992-07-29
HU212510B (en) 1996-07-29
DE59209915D1 (en) 2001-09-20
JPH06169770A (en) 1994-06-21
HUT63877A (en) 1993-10-28
EP0496327B1 (en) 2001-08-16
LTIP1532A (en) 1995-06-26
ES2164048T3 (en) 2002-02-16
FI920263A (en) 1992-07-23
HU9200127D0 (en) 1992-04-28
LT3948B (en) 1996-05-27
LV10974A (en) 1995-12-20
DK0496327T3 (en) 2001-12-03
ATE204326T1 (en) 2001-09-15
RU2108387C1 (en) 1998-04-10
IE914040A1 (en) 1992-07-29
HK1010108A1 (en) 1999-06-11
IL100163A0 (en) 1992-08-18
PT496327E (en) 2002-02-28
DE4101736A1 (en) 1992-07-23

Similar Documents

Publication Publication Date Title
CA2168429A1 (en) Expression of fusion polypeptides transported out of cytoplasm without leader sequences
DE3871798T2 (en) MODIFIED FACTOR VII / VIIA.
IT1153265B (en) POLYPEPTIDES CONTAINING THE SEQUENCE OF IMMUNE HUMAN INTERFERON AMINO ACIDS (HUMAN INTERFERONE RANGE), RELATED EXPRESSION VEHICLES, THEIR PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH POLYPEPTIDES
DE3770915D1 (en) HUMAN APOLIPOPROTEIN A1 AND ITS VARIANT, EXPRESSED IN ESCHERICHIA COLI.
AU7008887A (en) Novel human tissue-type plasminogen activator polypeptides
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
IL85020A0 (en) Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it
FI920263A0 (en) NYA POLYPEPTIDER, PLASMIDER SOM KODAR FOER DESSA SAMT FOERFARANDEN FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.
DE3462039D1 (en) Peptide derivatives, their preparation and use as elastase inhibitors
AR013618A1 (en) METHOD AND COMPOSITIONS FOR THE DISTRIBUTION AND EXPRESSION OF NUCLEIC ACIDS OF INTERFERON
ATE110389T1 (en) THF COMPOSITIONS.
GB1437477A (en) Synthetic peptides
ATE147268T1 (en) HYPOGLYCEMIC PEPTIDES
GB1425512A (en) N-n-n-n-n-5-oxo-l-prolyl-l-histidyl-l-triptophyl-l-seryl-l- tyrosyl- glycerine hydrazide trifluoroacetate